Search Results - "Reuss, David E"

Refine Results
  1. 1

    Updates on the WHO diagnosis of IDH-mutant glioma by Reuss, David.E.

    Published in Journal of neuro-oncology (01-05-2023)
    “…Purpose The WHO classification of Tumors of the Central Nervous System represents the international standard classification for brain tumors. In 2021 the 5th…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas by Pekmezci, Melike, Reuss, David E, Hirbe, Angela C, Dahiya, Sonika, Gutmann, David H, von Deimling, Andreas, Horvai, Andrew E, Perry, Arie

    Published in Modern pathology (01-02-2015)
    “…Cellular schwannoma is an uncommon, but well-recognized, benign peripheral nerve sheath tumor, which can be misdiagnosed as malignant peripheral nerve sheath…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells by Siegelin, Markus D, Reuss, David E, Habel, Antje, Rami, Abdelhaq, von Deimling, Andreas

    Published in Neuro-oncology (Charlottesville, Va.) (01-04-2009)
    “…The flavonoid quercetin has been reported to inhibit the proliferation of cancer cells, whereas it has no effect on nonneoplastic cells. U87-MG, U251, A172,…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin by Siegelin, Markus D, Reuss, David E, Habel, Antje, Herold-Mende, Christel, von Deimling, Andreas

    Published in Molecular cancer therapeutics (01-11-2008)
    “…Resistance to tumor necrosis factor–related apoptosis-inducing ligand (TRAIL/Apo2L) limits its potential as a drug for cancer therapy. Here, we report that…”
    Get full text
    Journal Article
  17. 17

    Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL is augmented by loss of NF1 through modulation of MYC/MAD and is potentiated by curcumin through induction of ROS by Reuss, David E, Mucha, Jana, Hagenlocher, Christian, Ehemann, Volker, Kluwe, Lan, Mautner, Victor, von Deimling, Andreas

    Published in PloS one (21-02-2013)
    “…Malignant peripheral nerve sheath tumor (MPNST) is a rare aggressive form of sarcoma often associated with the tumor syndrome neurofibromatosis type 1 (NF1)…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry by Longuespée, Rémi, Wefers, Annika K, De Vita, Elena, Miller, Aubry K, Reuss, David E, Wick, Wolfgang, Herold-Mende, Christel, Kriegsmann, Mark, Schirmacher, Peter, von Deimling, Andreas, Pusch, Stefan

    Published in Acta neuropathologica communications (02-03-2018)
    “…All isocitrate dehydrogenase (IDH) mutant solid neoplasms exhibit highly elevated levels of D-2-hydroxyglutarate (D-2HG). Detection of 2HG in tumor tissues…”
    Get full text
    Journal Article
  20. 20

    Heterogeneity of DNA methylation profiles and copy number alterations in 10782 adult-type glioblastomas, IDH-wildtype by Reuss, David E, Schrimpf, Daniel, Cherkezov, Asan, Suwala, Abigail K, Lausová, Tereza, Snuderl, Matija, Capper, David, Sill, Martin, Jones, David T W, Pfister, Stefan M, Sahm, Felix, von Deimling, Andreas

    Published in Free Neuropathology (2024)
    “…The morphological patterns leading to the diagnosis of glioblastoma may also commonly be observed in several other distinct tumor entities, which can result in…”
    Get full text
    Journal Article